(Source: Diabetes News, 23 April 2011)
Scientists at the Stanford University School of Medicine and the University of Toronto have showed that type 2 diabetes could derive from an autoimmune reaction from within the body. It is hoped the breakthrough will lead to new therapies for treating the condition.
The research, published in the journal Nature Medicine, found that an antibody called anti-CD20 was effective in treating laboratory mice with type 2 diabetes . Although more work is needed to test it on humans, the anti-CD20 can pinpoint and eliminate mature B cells, which could prevent the development of type 2 diabetes in those prone to the condition, as well as helping to replenish their blood sugar. Read more
0 comments:
Post a Comment